Teva Makes $40 Billion Cash-and-Stock Bid for Mylan

22.04.2015 - In what is shaping up to be the global pharmaceutical industry's latest hostile takeover struggle, the world's largest generic drugmaker, Israel-based Teva, has made a bid for...